Analystreport

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is now covered by analysts at Oppenheimer Holdings Inc.. They set a "hold" rating and a $92.00 price target on the stock.

BioMarin Pharmaceutical Inc.  (BMRN) 
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.biomarin.com